With people staying home as cases of the deadly virus continue to climb, stocks like these 5 are on the rise.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Buy Target $36.90 Sell Target $45.42 Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company’s lead products include ARV-110, proteolysis targeting chimeras (PROTAC) that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men […]
Read MorePlus, bank stocks are on the rise on reports of a change to the Volker Rule, the U.S. saw a record number of new coronavirus cases, last week’s jobless claims came in higher than expected, and Wirecard shares tanked after the troubled fintech filed for insolvency.
Read MoreOver the last several years, one of the biggest benchmarks the Fed has used to evaluate the need to raise, lower or maintain their interest rate policy has been the employment rate. Every month, the market seems to hold its breath as a new set of unemployment and salary data is made available and everybody […]
Read MoreBuy Price: $4.00 or better Sell Price: TradersPro Sell Signal Genprex, Inc. operates as a clinical-stage gene therapy company. The company engages in developing technologies for cancer patients based upon a proprietary technology platform. Its platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Buy Target $0.53 Sell Target $0.63 TETRA Technologies, Inc., together with its subsidiaries, operates as a diversified oil and gas services company. The company’s Completion Fluids & Products segment manufactures and markets clear brine fluids, additives, and associated products and services to the oil and gas industry for use in well drilling, completion, […]
Read MoreBuy Price: $6.25 or better Sell Price: TradersPro Sell Signal IVERIC bio, Inc., a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases. The company is developing Zimura, an inhibitor of complement factor C5, which is in Phase IIb clinical trials for the treatment of geographic […]
Read MorePlus, the White House is considering new tariffs on $3.1 billion of goods from the EU, the IMF again slashed its economic forecast for 2020, a trio of states in the northeast have imposed a 14-day quarantine for travelers from states in the U.S. that are seeing spikes of coronavirus cases, and Peloton got an upgrade.
Read MoreAs an analyst, I take a lot of interest in trying to find reasons the market stages some of the moves it makes. The factors, geopolitical, economic, or emotional, that drives trends over any time period can be widely varied, and sometimes it’s interesting to see not only what is influencing the market today, but […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Buy Target $10.43 Sell Target $12.34 CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer.
Read MoreBuy Price: $3.25 or better Sell Price: TradersPro Sell Signal Gerdau S.A. provides steel products and services in the United States and Canada. It operates through four segments: Brazil Operations, North America Operations, South America Operations, and Special Steel Operations. The company offers semi-finished products, including billets, blooms, and slabs; common long rolled products, such […]
Read MorePlus, stocks are up after President Trump said the U.S.-China phase one trade deal is still “fully intact” after confusion following a statement from trade advisor Peter Navarro, six global investors inked a $20.7 billion agreement with the Abu Dhabi National Oil Company, and Wirecard’s former CEO has been arrested.
Read More